Invention Grant
- Patent Title: Hematopoietic neoplasm chemotherapy
- Patent Title (中): 造血肿瘤化疗
-
Application No.: US14265844Application Date: 2014-04-30
-
Publication No.: US09044487B2Publication Date: 2015-06-02
- Inventor: Marcio Chedid
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent John C. Demeter
- Main IPC: A61K31/5513
- IPC: A61K31/5513 ; A61K31/5517
Abstract:
A method and medicament for treating mixed lineage leukemia; translocated mixed lineage leukemia; translocated mixed lineage leukemia based acute myelogenous leukemia; translocated mixed lineage leukemia based acute lymphoid leukemia; a non-MLL based chronic myeloproliferative disorder, or non-MLL based acute lymphoid leukemia is provided.
Public/Granted literature
- US20140235621A1 HEMATOPOIETIC NEOPLASM CHEMOTHERAPY Public/Granted day:2014-08-21
Information query
IPC分类:
